Related Experiment Video

Updated: Jun 14, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Akt-mTOR signaling is involved in Notch-1-mediated glioma cell survival and proliferation

Nengjiang Zhao1, Ya Guo, Mingfang Zhang

  • 1Department of Biochemistry and Molecular Biology, Research Center of Molecular Medicine, Fujian Medical University, Fuzhou 350004, P.R. China.

Oncology Reports
|April 8, 2010
PubMed

Insights

Notch-1 activation promotes glioma cell growth by activating the Akt-mTOR pathway. Suppressing Notch-1 inhibits glioma cell proliferation and induces apoptosis via this pathway.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Notch signaling and Akt-mTOR pathways are crucial for glioma cell proliferation and survival.
  • Notch-1 overexpression is observed in gliomas, and its inhibition can suppress tumor growth.
  • The precise molecular mechanisms linking Notch signaling to glioma progression remain unclear.

Purpose of the Study:

  • To elucidate the molecular mechanism by which Notch-1 influences glioma cell proliferation and survival.
  • To investigate the role of the Akt-mTOR signaling pathway in Notch-1-mediated glioma cell regulation.
  • To determine the effect of Notch-1 suppression on glioma cell apoptosis and key signaling molecules.

Main Methods:

  • Activation of Notch signaling using the intracellular domain of human Notch-1 (NIC-1) in U251 glioma cells.
  • Knockdown of Notch-1 using RNA interference.
  • Analysis of Akt and mTOR phosphorylation levels.
  • Assessment of apoptosis-related proteins, including MCL-1, PARP, caspase-9, and caspase-3.

Main Results:

  • Activation of Notch-1 strongly activated Akt and promoted U251 glioma cell proliferation.
  • Notch-1 knockdown suppressed Akt activation, reduced cell growth, and induced apoptosis.
  • Notch-1 suppression led to decreased phosphorylated Akt and mTOR.
  • Knockdown of Notch-1 resulted in downregulation of MCL-1 and activation of PARP, caspase-9, and caspase-3.

Conclusions:

  • Notch-1 positively regulates the Akt-mTOR pathway, contributing to glioma cell proliferation and survival.
  • Notch-1 RNA interference inhibits glioma cell proliferation through the Akt-mTOR signaling pathway.
  • Targeting Notch-1 offers a potential therapeutic strategy for glioma by modulating crucial cell signaling pathways.

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...